SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-10-000119
Filing Date
2010-02-03
Accepted
2010-02-03 16:42:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO THE SCHEDULE 13G sc13ga300322tap_12312009.htm SC 13G/A 228779
2 JOINT FILING AGREEMENT ex991to13ga300322tap_123109.htm EX-99.1 32396
  Complete submission text file 0000921895-10-000119.txt   263280
Mailing Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301
Business Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301 303-516-8500
TAPESTRY PHARMACEUTICALS, INC (Subject) CIK: 0000891504 (see all company filings)

IRS No.: 841187753 | State of Incorp.: DE | Fiscal Year End: 1228
Type: SC 13G/A | Act: 34 | File No.: 005-49101 | Film No.: 10571184
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice